Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huifang Lv

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
BMC Cancer|December 15, 2023
Immune checkpoint inhibitors enhanced the antitumor efficacy of disitamab vedotin for patients with HER2-positive or HER2-low advanced or metastatic gastric cancer: a multicenter real-world studyCaiyun Nie, Weifeng Xu, Yanwei Guo, et al.
Journal of Oncology|April 4, 2022
Retrospective Study on the Efficacy and Safety of Pyrotinib-Based Therapy for HER2-Positive Nonbreast Advanced Solid TumorsJianzheng Wang, Baiwen Zhang, Xiaojiao Cheng, et al.
Journal of Molecular Graphics & Modelling|February 26, 2017
Direct binding of microRNA-21 pre-element with Regorafenib: An alternative mechanism for anti-colorectal cancer chemotherapy?Xiaobing Chen, Bojian Xie, Liang Cao, et al.
AME Case Reports|January 27, 2025
Gastric cancer patient with <i>MET</i> amplification treated with crizotinib achieves long-term survival: a case reportWeifeng Xu, Caiyun Nie, Hui Wang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 6, 2025
Highly Stable S<sup>2-</sup>-Doped-rGO@Fe<sub>2.57</sub>Mn<sub>0.43</sub>O<sub>4</sub>@C Hybrid Heterostructures by Sulfur- Doping of Graphene-Coated 3D Fe<sub>2.57</sub>Mn<sub>0.43</sub>O<sub>4</sub> Nanorods on rGO Nanosheets for High-Performance Fast Charge/Discharge Ni/Fe BatteriesYan Wang, Zhiyu Zhou, Xiaofan Zhang, et al.
Cancer Cell International|July 3, 2025
Identification of molecular subtypes based on pseudouridine modification in hepatocellular carcinomaWeifeng Xu, Caiyun Nie, Zhen Liu, et al.
Journal of Oncology|February 7, 2022
Personalized Treatment of Advanced Gastric Cancer Guided by the MiniPDX ModelJianzheng Wang, Jinxi Huang, Hui Wang, et al.
Frontiers in Oncology|January 25, 2021
Knockdown of Kremen2 Inhibits Tumor Growth and Migration in Gastric CancerBeibei Chen, Sai-Qi Wang, Jinxi Huang, et al.
Neoplasma|March 31, 2025
Efficacy and prognostic factors of PD-1 inhibitors combined with apatinib in advanced diffuse gastric cancerBeibei Chen, Huichen Zhao, Huihui Hu, et al.
Frontiers in Molecular Biosciences|August 23, 2021
Overview on the Role of E-Cadherin in Gastric Cancer: Dysregulation and Clinical ImplicationsHuichen Zhao, Huihui Hu, Beibei Chen, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
BMC Cancer|December 15, 2023
Immune checkpoint inhibitors enhanced the antitumor efficacy of disitamab vedotin for patients with HER2-positive or HER2-low advanced or metastatic gastric cancer: a multicenter real-world studyCaiyun Nie, Weifeng Xu, Yanwei Guo, et al.
Journal of Oncology|April 4, 2022
Retrospective Study on the Efficacy and Safety of Pyrotinib-Based Therapy for HER2-Positive Nonbreast Advanced Solid TumorsJianzheng Wang, Baiwen Zhang, Xiaojiao Cheng, et al.
Journal of Molecular Graphics & Modelling|February 26, 2017
Direct binding of microRNA-21 pre-element with Regorafenib: An alternative mechanism for anti-colorectal cancer chemotherapy?Xiaobing Chen, Bojian Xie, Liang Cao, et al.
AME Case Reports|January 27, 2025
Gastric cancer patient with <i>MET</i> amplification treated with crizotinib achieves long-term survival: a case reportWeifeng Xu, Caiyun Nie, Hui Wang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 6, 2025
Highly Stable S<sup>2-</sup>-Doped-rGO@Fe<sub>2.57</sub>Mn<sub>0.43</sub>O<sub>4</sub>@C Hybrid Heterostructures by Sulfur- Doping of Graphene-Coated 3D Fe<sub>2.57</sub>Mn<sub>0.43</sub>O<sub>4</sub> Nanorods on rGO Nanosheets for High-Performance Fast Charge/Discharge Ni/Fe BatteriesYan Wang, Zhiyu Zhou, Xiaofan Zhang, et al.
Cancer Cell International|July 3, 2025
Identification of molecular subtypes based on pseudouridine modification in hepatocellular carcinomaWeifeng Xu, Caiyun Nie, Zhen Liu, et al.
Journal of Oncology|February 7, 2022
Personalized Treatment of Advanced Gastric Cancer Guided by the MiniPDX ModelJianzheng Wang, Jinxi Huang, Hui Wang, et al.
Frontiers in Oncology|January 25, 2021
Knockdown of Kremen2 Inhibits Tumor Growth and Migration in Gastric CancerBeibei Chen, Sai-Qi Wang, Jinxi Huang, et al.
Neoplasma|March 31, 2025
Efficacy and prognostic factors of PD-1 inhibitors combined with apatinib in advanced diffuse gastric cancerBeibei Chen, Huichen Zhao, Huihui Hu, et al.
Frontiers in Molecular Biosciences|August 23, 2021
Overview on the Role of E-Cadherin in Gastric Cancer: Dysregulation and Clinical ImplicationsHuichen Zhao, Huihui Hu, Beibei Chen, et al.
Pageof 9